• Obesity accounts for 8% of healthcare costs in Western Countries -$75 billion annually in US (2005) , $147 billion (2009) • Obesity is associated with "metabolic syndrome" -> type 2 diabetes and cardiovascular disease -Central (abdominal obesity) -Atherogenic dyslipidemia (high triglycerides, high LDL, low HDL) -Hypertension -Insulin resistance -Prothrombotic state -Pro-inflammatory state (elevated CRP)
• 34% of the US population are clinically obese (BMI > 30) -Double worldwide average (Flegal et al. JAMA 2010; 303:235-241) • Prevailing wisdom -"couch potato syndrome" -Positive energy balance, i.e., too much food, too little exercise
How does obesity occur ?
• Are there other factors in obesity ? -Stress (elevated glucocorticoids) -Inadequate sleep (stress?) -"Thrifty" genes which evolved to make the most of scarce calories -Viruses, gut microbes, SNPs
• What about role of prenatal nutrition or in utero experience? -Southampton studies -Maternal smoking decreases birth weight and increases obesity
• What about the role of industrial chemicals in rise of obesity? -Baillie-Hamilton (2002) postulated a role for chemical toxins -obesity epidemic roughly correlates with a marked increase in the use of chemicals (plastics, pesticides, etc.) • Many chemicals have effects on the endocrine system Resnick, ARCH DERMATOL (2001 ) 137, 1295 -1301 Hormonal control of weight In utero TBT exposure inhibits osteogenesis Kirchner et al., 2010 Molec Endocrinol, 24, 526-539 Effects of prenatal TBT on MSC pool
• TBT exposure biases the MSC compartment toward adipocytes -7-15% more pre-adipocytes in TBT-treated than control animals • Increased expression of adipocyte markers reflects increased number of pre-adipocytes -Decreased potential to form osteoblasts • Induction of adipogenesis is novel and unexpected endocrine disrupting effect of TBT
• Multiple potential modes of action -PPARγ-RXR -Aromatase expression/function -estradiol levels -Glucocorticoid levels -Other stressors?
Conclusions -organotins and obesity
• Is organotin exposure a contributing factor for obesity? -Adult exposure rapidly induces adipogenic genes • Drugs that activate PPARγ increase obesity -Prenatal TBT exposure permanently alters adult phenotype -Prenatal TBT exposure recruits MSCs to adipocyte lineage and diverts them from bone lineage
• Are humans exposed to sufficient levels of TBT for concern? -PVC is up to 3% w/w (0.1 M) organotins -Prevalent contaminants in dietary sources -Fungicide on high value crops, used in water systems -Average blood level of 27 nM in 32 random people tested -TPT levels from ~0.5-2 nM in Finnish fishermen
• Human exposure to organotins may reach levels sufficient to activate high affinity receptors -1000 x lower dose than natural dietary RXR and PPAR ligands
Is the environment making us fat? • Prenatal obesogen exposure reprograms exposed animals to be fat -Epigenetic changes alter fate of stem cell compartment -> more preadipocytes and more cells committed to adipocyte lineage
• Obesogens shift paradigm from treatment to prevention during pregnancy, childhood and puberty -Reduced exposure to obesogens, optimized nutrition -Obesity is intractable once established
